1. Hydrazones as promising lead with diversity in bioactivity-therapeutic potential in present scenario;Bala;Int. J. Pharm. Sci. Rev. Res.,2013
2. Local or systemic treatment for new world cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis;Blum;Int. Health,2012
3. Topical treatment for cutaneous leishmaniasis: dermato-pharmacokinetic lead optimization of benzoxaboroles;Bocxlaer;Antimicrob. Agents Chemother.,2018
4. Evaluating 5-nitrofurans as trypanocidal agents;Bot;Antimicrob. Agents Chemother.,2013
5. CDC (Centers for Disease Control and Prevention). 2022. Parasites - Leishmaniasis; https://www.cdc.gov/parasites/leishmaniasis/health_professionals/index.html#dx [Date accessed: 26 June 2022].